Skip to main content

Find Clinical Trials

Home
Conditions
Chronic Myeloproliferative Disorders

Clinical trial condition

Chronic Myeloproliferative Disorders

Explore clinical trials studying Chronic Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

94 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Chronic Myeloproliferative Disorders trial results

Completed

Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies

NCT00068523

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +68 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder

NCT00274820

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloproliferative Disorders, +16 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

NCT00054236

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +75 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

NCT00750009

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Treatment for Chronic Pain in Patients With Advanced Cancer

NCT00003687

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

McGill University Montreal, Quebec, Canada

View Trial Details

Completed

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

NCT00053989

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +67 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

CC-4047 in Treating Patients With Myelofibrosis

NCT00669578

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

NCT00036790

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +126 more
Locations: Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases

NCT00453206

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +67 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer

NCT00134017

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +66 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details